Rating History for Agomab Therapeutics (AGMB) by Leerink

More Stocks Rated by Leerink | Latest Ratings for AGMB
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/3/2026 N/A New Coverage Outperform
(N/A)		 36.00
(N/A)		 16.21
(11.84)		 -26.96% Details